The Effect of Epicutaneous Glucocorticostreroids on Human Monocyte and Neutrophil Migration in Vivo  by Norris, David A. et al.
0022-202X/82/7805-0386$02.00/0 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, 78:386-390, 1982 
Copyright © 1982 by The Williams & Wilkins Co. 
Vol. 78, No.5 
Print ed in U.S.A. 
The Effect of Epicutaneous Glucocorticosteroids on Human Monocyte 
and Neutrophil Migration in Vivo 
DAVID A. NORRIS, M.D., LESLIE CAPIN, B.A., WILLIAM L. WESTON, M.D. 
Department of Dermatology, University of Colorado School of Medicine, Denver, Colorado, U.S.A. 
The effect of epicutaneous methyl prednisolone (MP) 
at 10-\ 10-5, and 10-6 molar concentration was studied 
in 54 normal, healthy volunteers using a new, in vivo 
microchemotaxis technique. Significant inhibition of 
monocyte chemotaxis occurred at all concentrations 
studied and persisted over a 24-hr period with 10-4 molar 
MP. Neutrophil chemotaxis was significantly inhibited 
only with 10-4 MP. The inhibitory effect ofMP on neutro-
phil and monocyte chemotaxis occurred earlier and at 
lower concentrations if the skin sites were pretreated 
with steroid. Thus, when corticosteroids are applied on , 
abraded skin in concentrations achievable in vivo, mono-
cyte chemotaxis into tissue is inhibited for longer periods 
and at lower drug concentrations than is neutrophil 
chemotaxis. By avoiding the significant systemic effects 
of corticosteroids on circulating monocyte and neutro-
phil populations, these experiments establish that local 
inhibition of chemotaxis is an important anti-inflamma-
tory effect of corticosteroids, with differential effect on 
monocytes and neutrophils. 
During 20 years of clinical use, the efficacy of systemic and 
local glucorticosteroids has been clearly demonstrated in the 
treatment of immunologic and inflammatory disease, but the 
major site(s) of action of steroids provide a complex combina-
tion of immunosuppressive and anti-inflammatory effects. 
Corticosteroids are effective inhibitors of specific T lymphocyte 
functions. In man, the ability of T lymphocytes to respond to 
antigenic and mitogenic stimuli with a blastogenic response and 
lymphokine release is diminished with long-term daily steroid 
treatment, [1-5] but these effects may be due largely to the 
profound redistribution of the recirculating small lymphocytes, 
[6-10] produced rapidly by even alternate-day steroids. B cell 
function as manifested by antibody production is inhibited in. 
vitro and in. vivo by steroids, [11,12] and the ability of specific 
antibody to induce tissue inflammation is also inhibited by 
steroids. [13] 
In addition to these specific immunosuppressive effects of 
steroids, numerous significant anti-inflammatory effects of 
steroids alter the availability of nonspecific effector cells at 
tissue sites of inflammation and block the translation of specific 
immunologic signals into inflammatory responses. At clinically 
relevant doses, on alternate day regimens steroids produce a 
rapid but transient monocytopenia, lymphopenia, eosinopenia, 
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and a neutrophilia. [8-14] This is associated with a decreased 
availability of monocytes at sites of tissue inflammation [15-18] 
and in some instances a paradoxical decrease in neutrophil 
availability in tissue secondary to a decrease in the mluginal 
pool of neutrophils associated with diminished adherence of 
neutrophils to endothelial cells. [20-24] In contrast to the pro-
found changes in cell distribution and availability induced by 
systemic steroids, direct inhibition of monocyte and neutrophil 
function is difficult to achieve at phannacological concentra-
tions of steroids. [24-27] 
In evaluating the anti-inflammatory effect of steroids on 
tissue inflammation, it has been difficult to separate the sys-
temic effects on cell populations from local effects on the 
migration of effector cells into tissue. Previous studies of tissue 
applications of steroids have been either semiquantitative, have 
failed to accurately differentiate neutrophil and monocyte mi-
gration, have used nonpharmacological levels of drug or have 
used assays with inappropriate nonphysiological barriers to cell 
migration. [28-30] In the study presented here we have used a 
new in. vivo microchemotaxis technique to quantitatively test 
the effect oflocal steroids in pharmacological concentrations on 
monocyte and neutrophil migration toward complement-de-
rived chemotractants without the interfering influence of ste-
roids on peripheral blood cellular populations. We have dem-
onstrated that local inhibition of chemotaxis of monocytes and 
neutrophils in human tissue in. vivo is a significant anti-inflam-
matory effect of steroids. Monocytes are clearly more suscep-
tible to this effect than are neutrophils; the effect is dose and 
time dependent, and is achieved at steroid concentrations read-
ily obtained in. vivo. 
METHODS 
Subjects 
Various aspects of the effects of epicutaneous corticosteroids were 
studied in 54 normal human volunteers. Subjects served as their own 
controls. Persons with recent illness, ch.ronic skin disease, or who were 
taking medications were exclucl p.rl. 
Chemotaxis Technique 
Details of this quantitative in vivo neutrophil and monocyte che-
motaxis technique have been described previously. [31] Betadine and 
alcohol-sterilized skin was tape abraded with Blenderm tape (3M Co., 
St. Paul, MN) over 5-mm templates to produce 6 uniform glistening 
abrasions without macroscopic bleeding. Small plexiglass chambers of 
.2 ml volume containing 5U% zymosan activated autologous serum 
(ZAS) [32] diluted in Hanks Balanced Salt Solution (HBSS) were 
recovered with a Nucleopore filter sandwich (Nucleopore, Pleasanton, 
CAl composed of a 3 /l and a 5 /l pore filter and inverted over the 
abrasion. In this way, cells migrating from the abrasion toward the 
attractant were required to pass first through the 5 /l pore filter and 
then through the 3 /l pore filter. Monocytes were relatively relarded 
within the filter sandwich, while neutrophils passed more freely through 
the 3 /l pore ftlter. Chambers were kept in place for various periods and 
removed for quantitation. To determine the total number of cells which 
migrated, the 2 filter sandwich was removed and treated as follows: the 
attractant side of the 3}J. filter was scraped until glistening to remove 
the mass of neutrophils accumulated there, and the number of cells in 
t he scrapings were counted. The filter sandwich was separated and 
stained for monocyte esterase activity (alpha napthyl acetate esterase) 
[31,32] and mounted for counting. This stain a llows accurate differen-
tiation of monocytes, neutrophils and lymphocytes. Differential counts 
of monocytes and neutrophils were performed on each filter, and the 
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total number of each type of cell in 10 random fields was multiplied by 
a conversion factor to give the total number of cells per 5-mm abrasion. 
The total numbers of monocytes and neutrophils in the resuspended 
scraping and on the ftlters were added to obtain total monocyte and 
neutrophil migration. The relative numbers of neutrophils in the scrap-
ing versus those within the ftlters were not altered by steroids, nor was 
the relative percentage of monocytes which crossed to the 5 f.L and 3 f.L 
filter. With the filter combination chosen, and at the time studied, 
greater than 50% of the cells which did not cross the 3 f.L ftlter were 
monocytes, and fewer than 5% of the cells which did cross the ftlter 
were monocytes. Using this technique, lymphocytes were not shown to 
migrate in response to complement-derived chemotractants. 
Experimental Design 
In these experiments, subjects were used as their own controls by 
dividing 6 tape abrasions into 3 pairs. One member of each pair was 
covered with a chamber containing steroids or one containing HBSS 
diluent control. After the prescribed preincubation period, the chamber 
was removed and replaced with an attractant-containing chamber for 
the assay of subsequent monocyte and neutrophil migration . In this 
way the effect of varying steroid concentrations and periods of prein-
cubation of steroids on abraded skin was studied over different inter-
vals. Each data pair was analyzed independently and the significance 
of the effect of each variable was determined using a paired t-test. In 
this way, individual or anatomical variations in response were con-
trolled. 
The steroid used in these experiments was methyl prednisolone 
sodium succinate (SoluMedrlo, Upjohn Co., Kalamazoo, MI) , diluted 
in HBSS to concentrations that have been shown to be physiologic 
(IO- OM), pharmacological (lO-OM), and suprapharmacological (10- 'M). 
[34) The suprapharmacological concentration was included because it 
has not been clearly shown whether a concentration of corticosteroids 
at 10- 4 Molar might be achieved locally in vivo with application of 
clinically availab le topical preparations (l0- 3M) of corticosteroids. 
Subjects were grouped and such variables as steroid concentration, 
duration of preincubation, and duration of inhibition were studied, 
using each subject as his own control. Data were compiled both as 
absolute cell migration with and without steroids and also as the 
inhibition of migration in thousands of cells, which represents the 
numerical difference between each experimental chamber and its paired 
diluent control. 
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FIG 1. Effect of 10-" molar methyl prednisolone (MP) on monocyte 
and neutrophil migration at 4, 8, and 12 hr. The accumulation of cells 
in response to ZAS is shown after 4, 8, and 12 hr collections. Differential 
counts of monocytes and neutrophils are shown for abrasions which 
had been treated with epicutaneous MP or with HBSS control. The 
bars indicate mean cell migration in thousands ± standard error of the 
mean (SEM). Statistical significance-indicated above each pair of 
bars-was determined by paired t-testing of steroid and HBSS-pre-
treated chamber pairs. . 
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FIG 2. Effect of 10- 5 molar MP on monocyte and neutrophil migra-
tion at 4, 8, and 12 hr. 
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FIG 3. Effect of 10- 0 molar MP .on monocyte and neutrophil migra-
tion at 4, 8, and 12 hr. 
RESULTS 
The effect of preincubation of tape-abraded skin for 2 hI' with 
steroids is shown on cell migration at 4,8, and 12 hr in Fig 1-3 
for groups of subjects in which methyl prednisolone (MP) at 
10- 4, 10- 5, and 10- 6 Molar concentration was used. In Fig 1, 
significant inhibition by 10-" MP of both monocyte and neutro-
phil migration toward ZAS was seen at all times assayed. At 
1O- 5M MP, a concentration obtained with clinical systemic doses 
of steroids (Fig 2), both monocyte and neutrophil migration 
were still inhibited, but the duration and magnitude of inhibi-
tion were clearly greater for monocytes than for neutrophils. At 
10- 6 M MP (Fig 3), inhibition of chemotaxis was seen only with 
monocytes in experiments in which cells were collected for 12 
hours. 
Figure 4 shows the monocyte and neutrophil migration after 
24 hours in a group of subjects in which MP at 10- \ 10- 5 , and 
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1O- 6M concentration or HBSS controls were applied to abra-
sions 2 hr before application of attractant. Although there is 
inhibition in numbers of monocytes accumulated over that 
period, with all MP concentrations the result is significant only 
with lO- "M MP. With neutrophils, there was evident decrease 
in mean migration, but comparison to pail'ed controls shows no 
significant inhibition. Close analysis of individual data pail's 
shows that with 1O-6M MP and with concentrations of steroids 
at 24 hr, inhibition of neutrophil migration was highly variable 
from individual to individual. In other words, while neutrophil 
migration was inhibited in some individuals, in others it was 
not, suggesting an individual variability in susceptibility to low 
concentrations of steroids and individual variability in duration 
of effect at the lower limits of effective concentration. 
If one examines the effect of corticosteroids at different 
concentrations as the absolute decrease in thousands of migrat-
ing cells, it is clear that significant inhibition by steroids is 
clearly both concentration dependent and relatively cell type 
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FIG 4. Effect of MP on monocyte and neutrophil migration over 24 
hr. Migrating cells (in thousands) were collected over 24 Ill". Open bars 
are composite controls and shaded bars are the mean migration from 
abrasion sites pretreated for 2 hr with either 10- 4 , 10- ", or 10-" molar 
MP. Evaluation of data with a paired t-test inclicated that the progres-
sive decrease in migration at higher MP concentrations was not sig-
nificant (NS) except for monocytes at 10- 4 molar MP. 
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specific. Inhibition of monocyte chemotaxis in vivo by local MP 
occurs at lower concentrations and persists longer at higher MP 
concentrations than does inhibition of neutrophil chemotaxis. 
Although the magnitude of inhibition of neutrophil migration 
in absolute numbers is far greater than the inhibition of mono-
cyte migration, the relative percent inhibition is comparable 
between monocytes and neutrophils at concentrations where 
they are both susceptible. 
The importance of pretreatment with MP is ad(iTessed in the 
Table. The inhibition in thousands of cells per chamber by MP 
at 10- 4 and 10- " concentration is expressed for chambers in 
which the MP was added with chemotractant or in which the 
abrasion site was treated with MP before application of chem-
otractant. Although significant inhibition of monocyte chemo-
taxis was achieved with 10-" M MP with or without pretreat-
ment, pretreatment produced an earlier onset of effect. Inhibi-
tion of monocyte migration with 10- 5 M MP is also delayed in 
onset and never reaches significant levels without pretreatment 
of the tissue before application of atractant. The absolute 
magnitude of inhibition of neutrophil chemotaxis is even more 
significantly diminished by adding steroid to attractant without 
pretreatment, and again the onset of inhibition is delayed . From 
this experiment, however, one cannot be sure whether the delay 
in onset of effect or the limitation in magnitude of steroid-
induced inhibition of cell accumulation is due to direct interfer-
ence of activated serum with steroid penetration or to an 
absolute requirement of pretreatment of migrating cells and 
skin with steroids for maximal effect. 
DISCUSSION 
The demonstration of a dil"ect effect of epicutaneous corti-
costeroids on monocyte and neutrophil migration in vivo dem-
onstrates an imporant effect of steroids not clearly defined by 
previous in vivo and in vitro experiments. The technique used 
here to identify the local effect of steroids on cell ular migration 
provides several important advantages over the Rebuck Skin 
Window or other skin chamber techniques used previously to 
study cellular migration in vivo. This technique provides a 
physiological barrier to migration, a reservoil' of a known chem-
otractant, and quantitative differential counts of monocytes 
and neutrophils studied at different times. The barrier to mi-
gration is anatomically intact: tape stripping removes stratum 
corneum and some cells of the stratum granulosum. [35] Cells 
migrating into the chemotaxis chamber must pass through the 
postcapillary venules and the papillary dermis, through the 
basement membrane of the derma to-epidermal junction, and 
through an intact epidermis before accumulating within the 
Nucleopore filter sandwich. The attractant is autologous acti-
vated serum complement, without which only a weak neutro-
philic infiltrate develops. In the Rebuck technique, the abrasion 
of skin often removes most of the epidermis and itself induces 
Effect of 2 hr preincubation of methyl prednisolone on chemotaxis: !:J.M in. thousands (mean ± SEM) 
Pretreatment 
Monocytes 2 hr 
o hr 
:2 hr 
o hr 
Neutrophils 2 hr 
o hr 
2hr 
o hr 
" Compal'ed with paired medium control. 
MP 
Concentration 
lO- "M (n=6) 
lO- f'M (n=8) 
lO- "M (n=6) 
lO- r'M (n=8) 
4 hr 
6.0 ± 2.1 
p < .05" 
1.7 ± 4.3 
4.9 ± 2.9 
1.4 ± 1.0 
80.3 ± 19 
p < .01 
6.4 ± 7.1 
31 ± 15.4 
6.2 ± 9 
8 hI' 
14.0 ± 8.0 
p < .05 
20.7 ± 7.6 
p < .05 
12 ± 1.6 
p < .001 
10.9 ± 6 
107 ± 26 
p < .01 
27 ± 10 
P < .05 
32 ± 29 
44 ± 23 
12 hI" 
18.4 ± 5.0 
p < .0] 
15.8 ± 6.1 
p < .05 
25.8 ± 6.7 
p < .01 
3.9 ± 4.6 
168 ± 34 
p < .01 
27 ± 8 
p < .01 
20 ± 69.9 
69 ± 45 
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the migration of inflammatory cells even without the addition 
of exogenous attractants. Quantitation in the Rebuck Window 
technique requires migrated cells to attach to a glass coverslip 
applied to sites of abrasion. Since steroids affect cell adhesion, 
the decrease in numbers of cells counted with the Rebuck 
Window may merely represent a decrease in the ability of cells 
to attach to glass surfaces, rather than diminished migration. 
Conversely, in most skin chamber techniques, the cells are 
counted in the chamber fluid after detaching from the abraded 
surface through which they migrate. Steroid-induced detach-
ment from the abraded surface might cause the inhibitory 
effects of steroids on cell migration to be underestimated. In 
our microchemotaxis chamber technique, cells are counted as 
they migrate through a filter trap placed between attractant 
and abrasion-thus decreasing the effects on quantitation of 
steroid-induced reduction in cell adhesiveness. The use of uni-
form reservoirs for application of known steroid concentration 
in ow' technique allows the induction of significant local effect 
without the necessity of systemic administration of steroids. 
Such deficiencies in technique are reflected in previous re-
ports of the effects of steroids on cellular migration in vivo. 
Rebuck and Mellinger [29] reported significant inhibition of 
cellular infiltrates by local steroids, but the concentrations used 
were apparently suprapharmacological, the barrier to migration 
was limited, and quantitation was semi-quantitative. Peters et 
al [30] reported that the absolute numbers of leukocytes accu-
mulating in skin chambers in response to clotted serum actually 
increased with dexamethasone and decreased somewhat with 
prednisone; however, leukocyte clearance (migrated cells/ pe-
ripheral blood WBC) was diminished in both, reflecting the 
profound neutrophilia produced by both steroid preparations. 
In that study, differential migration of monocytes and neutro-
phils was not measured, the effect of steroids on the systemic 
availability of cells was misleading, and the measured end-
point-cells in suspension in the skin chamber after detachment 
from the abrasion-may have been differentially affected by 
such steroids with known differences in glucocorticoid potency. 
Several in vivo techniques have shown that systemic steroids 
ha ve a profound effect on monocyte availability at sites of tissue 
inflammation [k5,18] but again, it is not clear whether the effect 
on cellular availability was systemic or local. The most success-
ful attempt to addJ'ess the effect of steroids on monocyte and 
neutrophil chemotaxis in vivo was the investigation by Dale, 
Fauci, and Wolff of the Rebuck Skin Window response of 20 
patients with systemic inflammatory disease treated with daily 
and alternate day steroid therapy. [19] They found profound 
monocytopenia and decreased monocyte chemotaxis in patients 
on daily steroids on the "Day On" alternate day steroids. 
Neutrophilia and an elevated circulating neutrophil half-life 
was produced by daily steroids on the "Day On" alternate day 
steroids, but neutrophil chemotaxis in vivo was only depressed 
on daily steroids. Monocyte and neutrophil numbers and func-
tions were normal on the "Day Off' alternate day steroids. 
They established both a differential effect of steroids on mono-
cyte and neutrophil availability in tissue inflammation, and the 
apparent safety of alternate day steroid regimens in allowing 
effector cells to be available at sites of inflammation. However, 
the obligatory use of patients with significant immunologic 
disease as subjects likely selected a population with altered 
reactivity, as evidenced by the rather large differences in mono-
cyte chemotaxis in controls and patients on the "Day Off' 
steroids. Also, although the marginal pool of neutl'ophils was 
apparently decreased on the "Day On" alternate day steroids, 
neutrophil chemotaxis was normal. While monocyte accumu-
lation as judged by a weighted response over 24 ill' was normal 
on the "Day Off' steroids, migration between 12 and 24 h1' 
appeared to decrease for unexplained reasons. In the final 
analysis this classic study did not clea1'ly define the differences 
between local and systemic effects of steroids on monocyte and 
neutrophil migration in vivo, and encompassed the shortcom-
ings of the Rebuck Window technique: non physiological bar-
riel'S', poor attractant specificity, inadequate differentiation of 
monocytes and neutrophils, and dependence on cell adherance 
for counting and a semiquantitative endpoint. In contrast, the 
experiment which we present uses normal subjects who serve 
as their own controls, measures local and not systemic effects 
of corticosteroids, more clearly defines tissue dose response, 
provides quantitative specific differentiation of monocytes and 
neutrophils, and provides a timed picture of both induction and 
duration of inhibition. 
Examination of the effects of steroids on monocyte function 
in vitro has produced a confusing mosaic of positive and nega-
tive effects. Rhinehart et al. have shown that suprapharmaco-
logical concentrations of steroids in vitro inhibit monocyte 
chemotaxis, random migration, and staph bactericidal activity 
but do not affect neutrophil chemotaxis or monocyte crypto-
coccal phagocytosis, IgG receptor function or glass adherence. 
[36] On the other hand, when normal healthy subjects were fed 
significant clinical doses of steroids (prednisone 50 mg po q12h 
X 6), chemotaxis, cryptococcal phagocytosis, hexose monophos-
phate shunt activity, and ultrastructural features of harvested 
peripheral blood monocytes were not altered [37], only Staph 
Aureus and Candida tropicalis killing were depressed. It has 
also been shown [14] in patients receiving clinically relevant 
doses of alternate day steroids that chemotaxis, phagocytosis, 
and bacterial killing by periphel'81 blood monocytes were nor-
mal although profound monocytopenia occurred even at low 
doses of steroids. Other investigators have also shown variable 
effects on phagocytosis and killing of different organisms [38] 
and on monocyte maturation into macrophages [33] by steroids. 
Thus while it is easy to decrease the peripheral availability of 
monocytes with pharmacological doses of steroids, overt inhi-
bition of isolated in vitro monocyte functions , is difficult. A 
crucial problem in many experiments studying the effects of 
steroids on monocyte function in vitro is how to present the 
drug with appropriate carrier to potentiate cell absorption; [12] 
if this problem is not overcome, the levels of dJ'ug required to 
achieve effect in vitro are often much greater than those which 
in vivo will produce the same degree of effect [40]. Comparison 
of the difficulties in inhibitory monocyte chemotaxis in vitro 
with the same results presented here underscore this problem. 
We have demonstrated' that steroids presented locally in vivo 
in the millieu of serum and extracellular proteins clearly inhibit 
monocyte migration at pharmacological levels without any 
effect on the total monocyte pool available to tissue. In addition, 
this chemotaxis technique-which measures the ability of cells 
to cross vascular endothelium, the derma to-epidermal junction, 
and the epidermis-is a more critical and sensitive means of 
judging the total chemotactic response of monocytes than is 
measuring the cells' ability to cross or enter a thin filter in 
response to attractant. However, the effects attributed to ste-
roids by these experiments may not be due to alteration of the 
migratory machinery of inflammatory cells but may instead 
affect local margination or the cells' ability to cross endothe-
lium, ' dermato-epidermal junction or epidermis. 
The local effect of steroids on neutrophil availability in tissue 
is clearly less profound than the effect on monocytes. In vitro 
inhibition of neutrophil chemotaxis is achieved only at supra-
pharmacological levels [41,43]. At pharmacological levels, neu-
trophil adherance [24] but not chemotaxis [26,27] or phagocy-
tosis [43] are affected. 
The standard technique for evaluation of the potency of 
topically applied steroids is the vasoconstrictor assay of Mc-
Kenzie and Stoughton [44] which utilizes graded degrees of 
vasoconstriction to evaluate corticosteroid potency. The dem-
onstration of differential effects of steroids on monocyte and 
neutrophil accumulation in microchemotaxis chambers strongly 
suggests that vasoconstriction alone is not necessarily a repre-
sentative measure of the anti-inflammatory effects of steroids 
and further techniques for evaluating steroid potencies in vivo 
must consider the inlportant biological differences in monocyte 
and neutrophil susceptibility documented here. 
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